COMPANY
|
|
James Rossiter Appointed to President and Chief Executive Officer
San Francisco, CA - October 2, 2000
- Velos, Inc. today announced the appointment of James Rossiter
to President and Chief Executive Officer, succeeding John McIlwain
who transitioned to Chairman of the Board.
“Jim is a known
visionary in the healthcare industry and we are delighted he will
lead Team Velos in our next stage of growth,” noted Board Chairman
and Velos, Inc. founder, John McIlwain. “My enthusiasm for leading
Velos, Inc. is only surpassed by my excitement for the company’s
potential to be “best-of-breed” in customer service value,” said
Rossiter.
About James Rossiter James Rossiter’s experience
spans 18 years in technology general management, strategic business
development, and sales. Prior to joining Velos, Rossiter was a
leading eHealth consultant for IT vendors in business development,
eHealth strategies, early stage eHealth companies, and Venture
Capital firms. Rossiter is regarded as a thought leader in
developing key architectural components in the areas of Interface
Engine solutions, commercialization of controlled medical
terminology solutions, point of care clinical systems, and
healthcare decision support systems. Prior to eHealth consulting,
Mr. Rossiter was President of New Era of Networks’ Healthcare
Division, and CyberPlus Corporation. Mr. Rossiter's healthcare
career began at IBM Corporation in Sales and General Management,
where he ascended to Director of Clinical Solutions for IBM's Global
Healthcare organization.
About Velos
Velos, Inc. provides engines and services that power web delivery of business
infrastructure. Velos has a solution set in healthcare in the
business and clinical domains. Velos, Inc. is a privately held
corporation, headquartered in Silicon Valley with an office in
Minneapolis. For more information, please contact our web site:
www.velos.com.
This press release contains forward-looking
statements that are subject to risks and uncertainties that could
cause actual results to differ materially from those set forth in
the forward-looking statements. These forward-looking statements
represent the Company's judgment as of the date of this release. The
Company disclaims, however, any intent or obligation to update these
forward-looking statements.
|
|
